RVAC Medicines
PrivateLast Round
Series B
Apr 26, 2022
Total Funding Raised
$140M
Company Overview
RVAC Medicines is a biotechnology company developing an mRNA platform to build a diverse pipeline of innovative medicines and therapeutics to address unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RVAC Medicines Comps
Public and private peers based on sector, stage, and business model.
RVAC Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 26, 2022 |
RVAC Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CBC Group | Series B |
| EDBI | Series B |
| Pavilion Capital | Series B |
| GS Holdings | Series B |
RVAC Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about RVAC Medicines's valuation, stock price, and market status.
